EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 93 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,585,113 | +1208.4% | 4,487 | -80.1% | 0.43% | +1097.2% |
| Q1 2022 | $274,000 | +4.6% | 22,552 | +5.3% | 0.04% | -7.7% |
| Q4 2021 | $262,000 | -31.1% | 21,427 | -41.2% | 0.04% | +44.4% |
| Q3 2021 | $380,000 | -87.1% | 36,427 | -88.9% | 0.03% | -88.7% |
| Q2 2021 | $2,955,000 | -11.4% | 328,635 | 0.0% | 0.24% | +113.4% |
| Q1 2021 | $3,337,000 | +2704.2% | 328,635 | +1735.9% | 0.11% | +2140.0% |
| Q4 2020 | $119,000 | – | 17,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |